1. Home
  2. SEPN vs CTEV Comparison

SEPN vs CTEV Comparison

Compare SEPN & CTEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • CTEV
  • Stock Information
  • Founded
  • SEPN 2022
  • CTEV 1980
  • Country
  • SEPN United States
  • CTEV United States
  • Employees
  • SEPN N/A
  • CTEV N/A
  • Industry
  • SEPN
  • CTEV
  • Sector
  • SEPN
  • CTEV
  • Exchange
  • SEPN NYSE
  • CTEV NYSE
  • Market Cap
  • SEPN 311.6M
  • CTEV 371.3M
  • IPO Year
  • SEPN 2024
  • CTEV N/A
  • Fundamental
  • Price
  • SEPN $6.69
  • CTEV $21.83
  • Analyst Decision
  • SEPN Buy
  • CTEV Hold
  • Analyst Count
  • SEPN 4
  • CTEV 1
  • Target Price
  • SEPN $33.00
  • CTEV $19.00
  • AVG Volume (30 Days)
  • SEPN 181.2K
  • CTEV 53.5K
  • Earning Date
  • SEPN 05-19-2025
  • CTEV 05-08-2025
  • Dividend Yield
  • SEPN N/A
  • CTEV N/A
  • EPS Growth
  • SEPN N/A
  • CTEV N/A
  • EPS
  • SEPN N/A
  • CTEV N/A
  • Revenue
  • SEPN $1,075,000.00
  • CTEV $927,446,000.00
  • Revenue This Year
  • SEPN N/A
  • CTEV $2.18
  • Revenue Next Year
  • SEPN N/A
  • CTEV $3.04
  • P/E Ratio
  • SEPN N/A
  • CTEV N/A
  • Revenue Growth
  • SEPN 611.92
  • CTEV N/A
  • 52 Week Low
  • SEPN $4.17
  • CTEV $4.80
  • 52 Week High
  • SEPN $28.99
  • CTEV $31.00
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • CTEV N/A
  • Support Level
  • SEPN N/A
  • CTEV N/A
  • Resistance Level
  • SEPN N/A
  • CTEV N/A
  • Average True Range (ATR)
  • SEPN 0.00
  • CTEV 0.00
  • MACD
  • SEPN 0.00
  • CTEV 0.00
  • Stochastic Oscillator
  • SEPN 0.00
  • CTEV 0.00

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

About CTEV CLARITEV CORPORATION

Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.

Share on Social Networks: